Received Apr 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | 1 | Y015027 | OT / RL |
No additional adverse event; they did administer a dose of VAQTA to a patient the next clinic day after the needle had been attached; they did administer a dose of VAQTA to a patient the next clinic day after the needle had been attached; This spontaneous report was received from a nurse on 03-Mar-2025 and refers to a 12-month-old female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. The vaccine was primed to administer on 27-Feb-2025 (Thursday) at 02:21 pm. I was a pre-filled syringe primed with a needle. It was not administered so it was kept at appropriate temperatures to be used by the end of the day. It wasn't used by the end of that Thursday and should have been wasted but wasn't. On 28-Feb-2025, at 09:19 am, the patient was vaccinated with first dose of Hepatitis A Vaccine, Inactivated (lot #Y015027, expiration date: 06-Feb-2026), administered by intramuscular route in right thigh as prophylaxis. The vaccine was administered to the patient the next clinic day after the needle had been attached. It had been stored in the refrigerator with the needle attached for approximately 19 hours prior to being administered to a patient (Product use issue, Product preparation issue). There was no patient symptoms have been reported. No additional AE (no adverse event). The office policy was to waste any primed vaccines at end of day, and staff education was done. The vaccine was kept at appropriate temperatures that whole time.